InsiderTrades

Masson Kristina

SEC CIK 1950501 · EDGAR

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ACRVAcrivon Therapeutics, Inc.EVP - Business Ops, Dir 2.05M — — 152022-11-142025-11-21

Most active insiders at ACRV, 12 months

#InsiderTitleBoughtSold
1 Blume-Jensen PeterPres, CEO, Dir $82.3K$34.4K
2 Devroe EricCOO $17.2K$1,214
3 Levy Adam D.CFO $15.0K$1,793
4 Miller MaryCLO —$1,380
5 Gamelin ErickChief Development Off —$804.00
6 Peterson KatharineCAO —$203.01
7 Levin MichaelaChief Business Off ——
8 Palani SanthoshDir ——
9 Masson KristinaEVP - Business Ops, Dir ——
10 DiRocco DerekDir ——

Transactions 15

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2025-11-25 2025-11-21 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $2.30 -19.9K 2.05M -1.0% -$45.8K
I 2025-11-18 2025-11-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $2.24 -490 314.7K -0.2% -$1,098
2025-11-18 2025-11-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $2.24 -59.8K 2.07M -3% -$133.9K
2025-08-25 2025-08-21 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $1.32 -19.9K 2.13M -0.9% -$26.3K
I 2025-08-18 2025-08-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $1.39 -490 315.2K -0.2% -$681.10
2025-08-18 2025-08-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $1.39 -59.8K 2.15M -3% -$83.1K
2025-02-19 2025-02-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $5.42 -37.2K 2.31M -2% -$201.4K
I 2025-02-19 2025-02-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $5.42 -579 316.2K -0.2% -$3,138
2024-11-25 2024-11-21 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $6.44 -19.9K 2.34M -0.8% -$128.2K
2024-08-16 2024-08-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $7.02 -490 317.2K -0.2% -$3,440
2024-05-16 2024-05-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $8.36 -490 317.7K -0.2% -$4,096
2024-02-16 2024-02-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $3.40 -579 318.2K -0.2% -$1,969
2023-11-16 2023-11-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir F - Tax $5.08 -1,900 318.8K -0.6% -$9,652
DMI 2022-11-16 2022-11-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir A - Grant $0.00 +1.50M 2.31M +185% $0
D 2022-11-16 2022-11-14 ACRV Acrivon Therapeutics, Inc. Masson Kristina EVP - Business Ops, Dir A - Grant $0.00 +26.7K 320.7K +9% $0

Purchase Sale Sale after option exercise All abbreviations